Answers are grounded in this paper and cite their sources.
OBJECTIVE This study aims to assess the indications, complications, and outcomes of second-trimester genetic amniocentesis performed at Sanpatong Hospital, Chiang Mai, Thailand. METHODS A cross-sectional descriptive study analyzed data collected from high-risk pregnant women who underwent second-trimester genetic amniocentesis at Sanpatong Hospital between October 1st, 2016 and September 30th, 2022. The data include indications for the procedure, complications, and pregnancy outcomes. RESULTS A study of 451 women with high-risk pregnancies who underwent amniocentesis found that the most common indications for second trimester genetic amniocentesis were advanced maternal age (49.4%) and a high-risk Quad test (49.4%). Abnormal chromosomes were detected in 3.1% of cases, with aneuploidy the most common type (2.1%), primarily trisomy 21 (1.3%). The overall aspiration success rate was 100%. The only complications related to the procedure were pelvic pain (0.6%) and placental hematoma (0.2%). There were no fetal losses within 30 days after amniocentesis. The culture failure rate was 1.1%. Pregnancy outcomes included preterm delivery (12.3%) and normal term delivery (87.7%). CONCLUSIONS Performing second trimester genetic amniocentesis at Sanpatong Hospital, a mid-level secondary hospital, over a six-year period resulted in no fetal losses.
No takes yet. Share an insight, caveat, or question.
Ponglopisit et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: